TAF
ARGS

Tredje AP-fonden’s Argos Therapeutics, Inc. ARGS Stock Holding History

Tredje AP-fonden’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,822
Closed -$1M – 306
2015
Q2 		$1M Buy
+6,822
New +$1.09M 0.08% 263

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tredje AP-fonden's ARGS Position: Q3 2015 in Review

Tredje AP-fonden sold out of Argos Therapeutics, Inc. (ARGS) in Q3 2015, closing a stake of 6,822 shares — an estimated $1M sold.

Tredje AP-fonden first reported a position in ARGS in Q2 2015 and held it in 1 quarter. The position peaked at $1M in Q2 2015. 26 funds tracked by Wall St. Rank hold ARGS as of Q3 2015.

  • Tredje AP-fonden reported no remaining Argos Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Tredje AP-fonden sold 6,822 Argos Therapeutics, Inc. shares in Q3 2015, an estimated $1M.
  • Tredje AP-fonden first reported a position in Argos Therapeutics, Inc. in Q2 2015 and held it in 1 quarter.
  • Tredje AP-fonden's Argos Therapeutics, Inc. position peaked at $1M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2015.

Based on Tredje AP-fonden's 13F filing for Q3 2015, filed 10 Nov 2015.